What is Particles for Humanity?
Particles for Humanity operates at the intersection of medical innovation and humanitarian impact. The company specializes in developing affordable, scalable technologies designed to mitigate health disparities and combat preventable diseases. A cornerstone of their product portfolio is the PFH-VAP technology, which enhances the stability of vitamin A for food fortification, a critical intervention for improving nutritional outcomes in vulnerable communities. By focusing on high-impact, low-cost solutions, the company has established itself as a leader in social-impact medical engineering, ensuring that advanced scientific developments are accessible to billions of people globally.
How much funding has Particles for Humanity raised?
Particles for Humanity has raised a total of $19M across 3 funding rounds:
Grant
$5M
Unspecified
$4M
Grant
$10M
Grant (2020): $5M with participation from Bill & Melinda Gates Foundation
Unspecified (2022): $4M led by Mulago Foundation, Bill & Melinda Gates Foundation, and King Philanthropies
Grant (2023): $10M supported by Bill & Melinda Gates Foundation
Key Investors in Particles for Humanity
Bill & Melinda Gates Foundation
Established in 2000 and headquartered in Seattle, Washington, The Bill & Melinda Gates Foundation is an organization that focuses on supporting individuals experiencing hunger and extreme poverty in leading healthier lives.
Mulago Foundation
Mulago Foundation identifies scalable ideas and supports founders who can drive them to success, focusing on funding and teaching individuals with innovative solutions to poverty across various sectors.
King Philanthropies
King Philanthropies is dedicated to making a significant impact on the lives of the world's poorest individuals by enhancing the effectiveness of high-performing leaders and organizations while addressing barriers to economic development.
What's next for Particles for Humanity?
With the recent influx of capital, Particles for Humanity is positioned to scale its operational capacity and accelerate the deployment of its core medical technologies. The strategic roadmap likely involves expanding the reach of its food fortification initiatives and deepening its research into new, cost-effective medical interventions. As the company transitions through this major enterprise-level funding phase, the focus will remain on optimizing supply chains and strengthening partnerships with global health organizations to ensure long-term sustainability and measurable impact on global health outcomes.
See full Particles for Humanity company page
